HIV and AIDS Trial, Recruiting NCT06226155 Sponsor: Massachusetts General Hospital Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT06226155
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are currently pregnant
  • People attending antenatal care at Chitungwiza Central Hospital
  • People aged 15 or older
  • People who are willing to give their consent (or assent, for younger participants) to take part
  • People who have tested HIV negative
  • People who may be at risk of getting HIV — for example, those with a male partner whose HIV status is unknown, those who suspect their partner has other partners, those who have had more than one partner, those with a history of a sexually transmitted infection, or those who have recently had sex without a condom
  • People who score above 5 on the Shona Symptom Questionnaire (a mental health screening tool used in Zimbabwe)
  • For the main study (RCT) specifically: people who are willing to start PrEP (a medication that helps prevent HIV) before being enrolled into the study, and who are willing to bring their pregnancy partner to the study — if it is safe for them to do so

Who may not be able to join:

  • People who are unable to give informed consent or assent, or who are unable to take part in study procedures in either Shona or English
  • People who have a serious, unstable, or untreated mental health condition — such as active psychosis or untreated bipolar disorder — that would prevent them from fully participating in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amelia M Stanton, PhD, Boston University

Phone: 617-643-0385

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 October 2024
Est. completion
1 January 2027

Where this trial is recruiting

Zimbabwe

Primary endpoints

Feasibility (patient level); Acceptability (patient level); Feasibility (provider level); Acceptability (provider level)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov